undamentalytics Newsletter

Kyntra BIO, Inc. valuation and forecast

Explore the models for Kyntra BIO, Inc., adjust their assumptions and compare your own valuation with the platform's.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: data-quality checks not passed.

Price vs value

Under review: data-quality checks not passed. We'll show the comparison once resolved.

Analyst recommendations

5 analysts, Oct 2026
Buy480%
Hold120%
Sell00%

Monthly trend

  1. Oct 20261315
  2. Sep 2026314
  3. Aug 2026213
  4. Jul 2026213

Counts of recommendations published by analysts covering Kyntra BIO, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Price history

Loading chart…

Third-party market data · may be delayed

KYNB valuation questions

How does Fundamentalytics value Kyntra BIO, Inc.?
We use the models that fit Kyntra BIO, Inc.'s business and available financial data: price-to-sales vs peers. Each model has its own assumptions and data requirements. The calculator explains which models are available and lets you adjust their inputs.

Data: SEC EDGAR filings, retrieved October 29, 2026. Method: how we value companies. Disclosures: research and recommendations disclosure. Back to Kyntra BIO, Inc.

Compare with peers